Litigation Details for AMARIN PHARMA, INC. v. ROXANE LABORATORIES, INC. (D.N.J. 2014)
✉ Email this page to a colleague
AMARIN PHARMA, INC. v. ROXANE LABORATORIES, INC. (D.N.J. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-04-21 |
| Court | District Court, D. New Jersey | Date Terminated | 2014-10-02 |
| Cause | 35:271 Patent Infringement | Assigned To | Mary Little Cooper |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Parties | AMARIN PHARMACEUTICALS IRELAND LIMITED | ||
| Patents | 8,293,728; 8,318,715; 8,357,677; 8,367,652; 8,377,920; 8,399,446; 8,415,335; 8,426,399; 8,431,560; 8,440,650; 8,501,225; 8,518,929; 8,524,698; 8,546,372; 8,551,521; 8,617,594 | ||
| Attorneys | AMY MEGAN HANDLER | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AMARIN PHARMA, INC. v. ROXANE LABORATORIES, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for AMARIN PHARMA, INC. v. ROXANE LABORATORIES, INC. (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-04-21 | 1 | of U.S. Patent No. 8,293,728 (“the ‘728 Patent”), U.S. Patent No. 8,318,715 (“the ‘715 Patent”), U.S.…29 above. 31. United States Patent No. 8,293,728, entitled “METHODS OF TREATING HYPERTRIGLYCERIDEMIA…PageID: 3 ‘677 Patent”), U.S. Patent No. 8,367,652 (“the ‘652 Patent”), U.S. Patent No. 8,377,920 (“…(“the ‘920 Patent”), U.S. Patent No. 8,399,446 (“the ‘446 Patent”), U.S. Patent No. 8,415,335 (“the … ‘335 Patent”), U.S. Patent No. 8,426,399 (“the ‘399 Patent”), U.S. Patent No. 8,431,560 (“the ‘560 | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
